Ultralife Corp. (ULBI) Misses Q1 EPS by 3c

Ultralife Corp. (NASDAQ: ULBI) reported Q1 EPS of $0.11, $0.03 worse than the analyst estimate of $0.14. Revenue for the quarter came in at $50.7 million versus the consensus estimate of $48 million.

For earnings history and earnings-related data on Ultralife Corp. (ULBI) click here.

You May Also Be Interested In

• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• MiniMed launches Abbott Instinct sensors in Europe for its insulin systems
• Piper Sandler on Fervo Energy (FRVO): 'Capital Access Supports Potential Upside'